Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10021


Purpose:

The purposes of this study are to provide medical management by giving treatment to the mother that will bring up the fetal platelet count and to minimize the number of invasive procedures to the fetus (which may result in serious fetal injuries).


Criteria:

Inclusion Criteria: Pregnant women are eligible for inclusion into the Very High Risk Group if they: - are PLA-1 negative and have known platelet incompatibility with their fetus - have had a previous child who suffered an antenatal hemorrhage prior to 28 weeks gestation (as best as could be estimated) - are less than 19 weeks gestation Pregnant women are eligible for inclusion into the High Risk Group if they: - are PLA-1 negative and have known platelet incompatibility with the fetus - have had a previous child who suffered an antenatal hemorrhage after 28 weeks gestation (as best as could be estimated) - are between 12-30 weeks gestation Pregnant women are eligible for inclusion into the Standard Risk Group if they: - are PLA-1 negative and have known platelet incompatibility with the fetus - have not had a previous child who suffered an antenatal hemorrhage - are between 20-30 weeks gestation Exclusion Criteria: Women are not eligible for inclusion into the Very High Risk Group if they: - have had a previous child who suffered an antenatal hemorrhage after 28 weeks gestation - are greater than 19 weeks gestation Women are not eligible for inclusion into the High Risk Group if they: - have had a previous child who suffered an antenatal hemorrhage prior to 28 weeks gestation - are greater than 30 weeks gestation Women are not eligible for inclusion into the Standard Risk Group if they: - have had a previous child who suffered an antenatal hemorrhage - are greater than 30 weeks gestation


NCT ID:

NCT00194987


Primary Contact:

Principal Investigator
James B Bussel, M.D.
Weill Medical College of Cornell University


Backup Contact:

N/A


Location Contact:

New York, New York 10021
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.